The Veteran's onychomycosis with eczematous dermatitis is currently rated at 10 percent prior to April 10, 2012. From that date forward, the condition warrants a rating of no more than 60 percent.
The deciding factor: VA treatment records show intermittent use of topical corticosteroids for the Veteran's eczematous dermatitis and onychomycosis, meeting the criteria for a 10% evaluation under DC 7806. However, there is no evidence of worsening that would warrant an evaluation in excess of 60 percent.
- Claimed conditions
- onychomycosis, eczematous dermatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- October 12, 2017
- Citation
- 1745374
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1745374.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for an initial compensable disability rating for onychomycosis was denied as the condition did not require treatment and covered less than 5% of his body. The Board also remanded issues regarding service connection for left ear hearing loss and entitlement to a compensable disability rating for right ear hearing loss.
- Remanded (sent back)
The Veteran's claims for increased ratings of his service-connected toenail disabilities and service connection for lumbosacral strain, joint pain, and an acquired psychiatric disorder are being remanded due to the need for further development.
- Dismissed
The Veteran withdrew his appeals for all the listed conditions in April 2024 and March 2025, thus dismissing the appeal.
- Remanded (sent back)
The Veteran's onychomycosis is rated under the old criteria and remanded for further development to determine if systemic therapy, such as fluconazole, is similar to corticosteroids or immunosuppressive drugs.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.